-
Product Insights
NewLikelihood of Approval Analysis for Arthritis
Overview How likely is it that the drugs in Arthritis will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Arthritis Overview Inflammation in joints is referred to as arthritis. Rheumatoid arthritis and...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Designer EDV in Solid Tumor
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Designer EDV in Solid Tumor report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Designer EDV in Solid Tumor Drug Details: Designer EDV is...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Tumor Lysate, Particle Only (TLPO) Vaccine in Ovarian Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Tumor Lysate, Particle Only (TLPO) Vaccine in Ovarian Cancer report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Tumor Lysate, Particle Only (TLPO) Vaccine...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Tumor Lysate, Particle Only (TLPO) Vaccine in Melanoma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Tumor Lysate, Particle Only (TLPO) Vaccine in Melanoma report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Tumor Lysate, Particle Only (TLPO) Vaccine in...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Tumor Lysate, Particle Only (TLPO) Vaccine in Solid Tumor
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Tumor Lysate, Particle Only (TLPO) Vaccine in Solid Tumor report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Tumor Lysate, Particle Only (TLPO) Vaccine...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Tumor Lysate, Particle Only (TLPO) Vaccine in Non-Small Cell Lung Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Tumor Lysate, Particle Only (TLPO) Vaccine in Non-Small Cell Lung Cancer report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Tumor Lysate, Particle Only...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Designer EDV in Solid Tumor
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. Designer EDV in Solid Tumor Drug Details: Designer EDV is under development for the treatment...
-
Track & Monitor
Batteries in automotive: Battery pack swapping
Our team of industry experts has meticulously researched and analyzed the latest trends, innovations and emerging technologies in the automotive industry’s Battery pack swapping segment. By leveraging our report, you will gain invaluable insights that can revolutionise your business strategies and give you a competitive edge. Note: This is an “on-demand” report and will be delivered within 2 to 4 business days (excluding weekends and holidays) of the purchase. Certain sections in the report may be removed or altered based...
-
Track & Monitor
Batteries in automotive: Fire-proof battery packs
Our team of industry experts has meticulously researched and analyzed the latest trends, innovations and emerging technologies in the automotive industry’s Fire-proof battery packs segment. By leveraging our report, you will gain invaluable insights that can revolutionise your business strategies and give you a competitive edge. Note: This is an “on-demand” report and will be delivered within 2 to 4 business days (excluding weekends and holidays) of the purchase. Certain sections in the report may be removed or altered based...
-
Case Studies
Non-Alcoholic Beverages Packaging Opportunities – New Packaging Formats and Value-added Features
Category Packaging Opportunities: Non-Alcoholic Beverages explores new packaging formats and value-added features in the non-alcoholic beverages categories, using examples from GlobalData's Pack-Track innovation tool. With a huge and varied range of products on the retail shelf, it can be difficult for brand owners to offer something unique to consumers. Packaging is a key element that can provide differentiation and important added-value benefits. By using packaging to improve convenience and functionality it is possible to adapt to changing consumer lifestyles. Packaging...